Clinical Trial Update: A Study of HRS9531 Injection in Obese Subjects With Obstructive Sleep Apnea [Phase 2]

View source ↗

Summary

Phase 2 study of HRS9531 Injection in obese adults with obstructive sleep apnea; the trial is currently NOT_YET_RECRUITING and focuses on weight management.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Obstructive Sleep Apnea

Drugs mentioned

• HRS9531 Injection (HRS9531)

Snippet

Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. | Conditions: Weight Management | Phase 2 | Status: NOT_YET_RECRUITING